Simon Campion will be the new CEO of Dentsply Sirona (Nasdaq:XRAY) as it wraps up an internal investigation into potentially iffy financial practices. Campion will join the Dentsply Sirona board on Sept. 12, according to a news release out yesterday. He takes over for interim CEO John Groetelaars, the former Hillrom CEO who has led […]
BD
BD wins patent lawsuit against Baxter over drug-transfer system
BD (NYSE:BD) picked up a legal victory in a patent spat with Baxter (NYSE:BAX) over a system for moving drugs. A federal judge in Chicago ruled that BD’s PhaSeal system for transporting hazardous drugs between syringes and vials doesn’t infringe two patents belonging to Baxter. U.S. District Judge Joan H. Lefkow granted BD summary judgment […]
BD, Accelerate Diagnostics partner on rapid antibiotic testing
BD (NYSE:BDX) announced that it entered into a worldwide commercial collaboration agreement with Accelerate Diagnostics (Nasdaq:AXDX). Under the agreement announced earlier this week, BD will offer Accelerate’s rapid testing products and services for antibiotic resistance and susceptibility. Results arrive in hours compared to between one and two days with some traditional laboratory methods. Anti-biotic-resistant infections […]
Shareholder lawsuit over BD’s Alaris pumps recall moves forward
A federal judge in New Jersey is allowing part of a shareholder lawsuit to proceed against BD (NYSE: BDX) and CEO Thomas Polen over how they communicated company performance amid increasingly serious Alaris infusion pump problems. In an Aug. 11 opinion, Judge Stanley R. Chesler dismissed Industriens Pensionsforsikring’s claims against former BD CEO Vincent Forlenza […]
BD, Labcorp collaborate on flow cytometry-based diagnostics
BD (NYSE:BDX) announced today that it entered into a collaboration with Labcorp (NYSE:LH) to develop diagnostics. The collaboration aims to create the framework to develop, manufacture, market and commercialize flow cytometry-based companion diagnostics (CDx) intended to match patients with life-changing treatments for cancer and other diseases. Under the agreement, BD and Labcorp Drug Development will […]
BD makes tender offers for up to $500M of its debt
BD (NYSE:BDX) announced today that it has commenced tender offers to use cash to buy up to $500 million in debt securities from their holders. The move comes nearly five months after BD said it was making tender offers for notes worth up to $200 million. Just last week, BD released Q3 results that beat […]
BD beats The Street in Q3, raises guidance
BD (NYSE: BDX) today announced third-quarter results that beat the consensus forecast on Wall Street and raised both its revenue and EPS guidance, even as management acknowledged a challenging macroeconomic environment. The Franklin Lakes, N.J.–based medtech giant earned $360 million, or $1.28 per share, off $4.64 billion in sales for the quarter ended June 30, […]
6 drug delivery innovations you need to know
From wearable insulin delivery devices to drug-eluting implants and everything in between, drug delivery innovation never stops. Vaccines, life-saving therapeutics, vision-correcting drugs and more are being developed and marketed for delivery with all kinds of technologies. More than a year ago, we compiled a list of eight drug delivery innovations you need to know. With some […]
BD, CerTest launch monkeypox diagnostic for lab research outside the U.S.
BD (NYSE:BDX) and CerTest Biotec announced today that they made their monkeypox virus diagnostic commercially available. The newly developed molecular polymerase chain reaction (PCR) test for monkeypox has been made available outside of the U.S. for use in research applications by laboratories. Franklin Lakes, New Jersey-based BD and Zaragoza, Spain-based CerTest announced a partnership to […]
The biggest medtech personnel moves so far in 2022
In the ever-changing world of medtech, those who are leading the companies are bound to move around a bit. At the end of last year, we compiled a list of medtech’s biggest personnel changes in 2021. So far in 2022, we’ve already seen a slew of major moves involving some of the space’s most powerful […]
BD completes Parata Systems acquisition
BD (NYSE:BDX) announced today that it completed its previously announced acquisition of pharmacy automation company Parata Systems. Franklin Lakes, New Jersey-based BD announced last month that it partnered with private equity firm Frazier Healthcare Partners to acquire Parata Systems at a purchase price of $1.525 billion. Parata Systems provides medication adherence packaging technology and perpetual […]